Indegene Ltd Stock Falls to 52-Week Low of Rs.439.9 Amid Market Downturn

Mar 12 2026 11:12 AM IST
share
Share Via
Indegene Ltd, a key player in the Healthcare Services sector, has declined to a fresh 52-week low of Rs.439.9, marking a significant downturn in its stock performance amid broader market pressures and sectoral headwinds.
Indegene Ltd Stock Falls to 52-Week Low of Rs.439.9 Amid Market Downturn

Stock Performance and Price Movements

On 12 Mar 2026, Indegene Ltd's share price touched an intraday low of Rs.439.9, representing a decline of 2.16% on the day. This new low also marks the stock’s all-time lowest trading level. The stock has been on a downward trajectory for nine consecutive trading sessions, resulting in a cumulative loss of 11.09% over this period. This sustained decline has seen the stock underperform its sector by 0.73% on the day, reflecting relative weakness within Healthcare Services.

Further technical analysis reveals that Indegene is currently trading below all major moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This broad-based weakness across short, medium, and long-term moving averages underscores the prevailing bearish sentiment surrounding the stock.

Market and Sector Context

The broader market environment has also been challenging. The Sensex opened lower at 76,369.65, down 494.06 points or 0.64%, and was trading at 76,451.13, down 0.54% at the time of reporting. The index has been on a three-week losing streak, shedding 7.68% in that timeframe. Notably, the Sensex is trading below its 50-day moving average, which itself is positioned below the 200-day moving average, a technical configuration often interpreted as bearish.

Several indices, including the S&P Bse Dollex 30, S&P Bse FMCG, and NIFTY FMCG, also hit new 52-week lows on the same day, indicating widespread sectoral and market weakness. This environment has likely contributed to the pressure on Indegene’s stock price.

Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!

  • - Expert-scrutinized selection
  • - Already delivering results
  • - Monthly focused approach

Get Next Month's Pick →

Technical Indicators and Market Sentiment

Technical indicators for Indegene Ltd present a predominantly bearish outlook. The Moving Average Convergence Divergence (MACD) on a weekly basis signals bearish momentum, while the monthly MACD remains neutral. The Relative Strength Index (RSI) on a weekly scale shows a bullish signal, though the monthly RSI does not provide a clear trend.

Bollinger Bands on both weekly and monthly charts indicate bearish conditions, suggesting increased volatility and downward pressure. The daily moving averages also reflect a bearish trend, consistent with the stock’s recent price action. The Know Sure Thing (KST) indicator on a weekly basis is bearish, with no clear monthly signal. Dow Theory assessments on both weekly and monthly timeframes confirm a bearish stance. The On-Balance Volume (OBV) indicator is mildly bearish on a weekly basis, with no definitive trend on the monthly chart.

These technical signals collectively point to a cautious environment for the stock, with downward momentum prevailing across multiple timeframes and indicators.

Valuation and Market Capitalisation

Indegene Ltd currently holds a Mojo Score of 47.0, which corresponds to a Mojo Grade of Sell, downgraded from Hold as of 23 Feb 2026. The company’s market capitalisation grade stands at 3, reflecting its mid-cap status within the Healthcare Services sector. This grading shift indicates a reassessment of the stock’s relative attractiveness in the current market context.

Why settle for Indegene Ltd? SwitchER evaluates this Healthcare Services small-cap against peers, other sectors, and market caps to find you superior investment opportunities!

  • - Comprehensive evaluation done
  • - Superior opportunities identified
  • - Smart switching enabled

Discover Superior Stocks →

Historical Price Context

The stock’s 52-week high was recorded at Rs.632.1, indicating a significant decline of approximately 30.4% from that peak to the current 52-week low of Rs.439.9. This wide price range over the past year highlights the volatility experienced by Indegene Ltd shares and reflects the broader challenges faced by the Healthcare Services sector during this period.

Despite the recent lows, the stock’s performance must be viewed in the context of the overall market environment, which has been characterised by bearish trends and sectoral pressures. The Sensex’s own technical positioning and recent losses have contributed to a cautious investment climate.

Sectoral and Market Influences

The Healthcare Services sector, to which Indegene belongs, has faced headwinds as evidenced by the underperformance of related indices and stocks. The sector’s sensitivity to regulatory changes, pricing pressures, and evolving healthcare demands may have influenced investor sentiment. Additionally, the broader market’s bearish tone, with key indices hitting 52-week lows, has compounded the downward pressure on stocks like Indegene.

Trading volumes and liquidity considerations, while not detailed here, often play a role in such price movements, especially in mid-cap stocks. The stock’s consistent fall over nine sessions suggests a sustained selling interest, possibly reflecting profit-taking or repositioning by market participants.

Summary of Key Metrics

To summarise, Indegene Ltd’s stock has reached a new 52-week low of Rs.439.9, down 2.16% on the day and down 11.09% over the last nine trading sessions. The stock is trading below all major moving averages, with technical indicators predominantly bearish. The Mojo Grade has been downgraded to Sell from Hold as of late February 2026. The broader market and sector environment remain subdued, with the Sensex and several sectoral indices also at 52-week lows and exhibiting bearish technical patterns.

These factors collectively illustrate the challenges faced by Indegene Ltd’s stock in the current market cycle, reflecting both company-specific and macroeconomic influences within the Healthcare Services sector.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Indegene Ltd Stock Falls to 52-Week Low of Rs 433.7
Mar 13 2026 10:16 AM IST
share
Share Via
Indegene Ltd Stock Falls to 52-Week Low of Rs 445.5
Mar 09 2026 02:07 PM IST
share
Share Via
Indegene Ltd is Rated Sell
Mar 07 2026 10:10 AM IST
share
Share Via